No Data
No Data
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Shares Lagging The Market But So Is The Business
CR Sanjiu's H1 Profit Jumps 28% on Higher Revenue
China Resources Sanjiu Medical & Pharmaceutical: Summary of Half-Year Report in 2024.
China Resources Sanjiu Medical & Pharmaceutical: Half-year report for the year 2024.
Selected Announcements | Zijin Mining Group: Net income attributable to the parent company in the first half of the year was 15.084 billion yuan, a year-on-year increase of 46.42%. The company plans to distribute a dividend of 1 yuan per 10 shares. Aier E
Goldwind Science & Technology: Plans to spend 0.25 to 0.5 billion yuan to repurchase shares.
China resources sanjiu medical & pharmaceutical (000999.SZ): net income of 2.398 billion yuan in the first half of the year, a year-on-year increase of 27.77%.
China Resources Sanjiu Medical & Pharmaceutical (000999.SZ) announced its semi-annual report with revenues of 14.1 billion yuan, a year-on-year growth of 7.30%, net income of 2.398 billion yuan, a year-on-year growth of 27.77%, non-GAAP net income of 2.3 billion yuan, a year-on-year growth of 26.33%, and basic earnings per share of 1.87 yuan.
No Data